<p>Proportion of patients who permanently discontinued all therapy due to adverse events after stratifying for baseline platelet count and albumin concentration. Data was available in 46 patients.</p
Objectives: To estimate rates of discontinuation and restarting of statins, and to identify patient...
<p>Proportion of patients discontinuing from the AmoCongo ART program over time.</p
Abstract Background We tried to evaluate the prevalence of premature discontinuation of antiplatelet...
<p>(Upper panel) Cumulative incidence of discontinuation during the follow-up period. The unadjusted...
OBJECTIVE: To assess patterns of restarting antihypertensive drugs after a prolonged period of disco...
OBJECTIVES: To estimate rates of discontinuation and restarting of statins, and to identify patient ...
Statins are among the most widely prescribed drugs.They reduce atherosclerotic cardiovascular diseas...
Randomized controlled trials haveshown beneficial effects of hydrox-ymethylglutaryl-coenzyme A reduc...
<p>Data are presented as number of discontinuation events with annual probability of discontinuation...
<p>All p values were calculated using Fisher’s exact tests. Only statistically significant p values ...
OBJECTIVES: To assess rates and determinants of treatment discontinuation of or changes in initial ...
Showing the number of patients discontinuing therapy and the primary documented causes by drug group...
Background: Systematic data on discontinuation of statins in rou-tine practice of medicine are limit...
Shown are the percentages of patients remaining after lack of efficacy (LoE) discontinuation in stud...
OBJECTIVES: To assess rates and determinants of treatment discontinuation of or changes in initial a...
Objectives: To estimate rates of discontinuation and restarting of statins, and to identify patient...
<p>Proportion of patients discontinuing from the AmoCongo ART program over time.</p
Abstract Background We tried to evaluate the prevalence of premature discontinuation of antiplatelet...
<p>(Upper panel) Cumulative incidence of discontinuation during the follow-up period. The unadjusted...
OBJECTIVE: To assess patterns of restarting antihypertensive drugs after a prolonged period of disco...
OBJECTIVES: To estimate rates of discontinuation and restarting of statins, and to identify patient ...
Statins are among the most widely prescribed drugs.They reduce atherosclerotic cardiovascular diseas...
Randomized controlled trials haveshown beneficial effects of hydrox-ymethylglutaryl-coenzyme A reduc...
<p>Data are presented as number of discontinuation events with annual probability of discontinuation...
<p>All p values were calculated using Fisher’s exact tests. Only statistically significant p values ...
OBJECTIVES: To assess rates and determinants of treatment discontinuation of or changes in initial ...
Showing the number of patients discontinuing therapy and the primary documented causes by drug group...
Background: Systematic data on discontinuation of statins in rou-tine practice of medicine are limit...
Shown are the percentages of patients remaining after lack of efficacy (LoE) discontinuation in stud...
OBJECTIVES: To assess rates and determinants of treatment discontinuation of or changes in initial a...
Objectives: To estimate rates of discontinuation and restarting of statins, and to identify patient...
<p>Proportion of patients discontinuing from the AmoCongo ART program over time.</p
Abstract Background We tried to evaluate the prevalence of premature discontinuation of antiplatelet...